192 related articles for article (PubMed ID: 7746735)
21. Variable expression of Epstein-Barr virus latent membrane protein I in Reed-Sternberg cells of Hodgkin's disease.
Teramoto N; Cao L; Kawasaki N; Tonoyama Y; Sarker AB; Yoshino T; Takahashi K; Akagi T
Acta Med Okayama; 1996 Oct; 50(5):267-70. PubMed ID: 8914680
[TBL] [Abstract][Full Text] [Related]
22. EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products.
Hummel M; Anagnostopoulos I; Dallenbach F; Korbjuhn P; Dimmler C; Stein H
Br J Haematol; 1992 Dec; 82(4):689-94. PubMed ID: 1336392
[TBL] [Abstract][Full Text] [Related]
23. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
Delsol G; Brousset P; Chittal S; Rigal-Huguet F
Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
[TBL] [Abstract][Full Text] [Related]
24. Major histocompatibility complex (MHC)-I and MHC-II expression in Hodgkin's disease in relation to the presence of Epstein-Barr Virus (EBV).
Tzardi M; Kouvidou C; Papakonstantinou E; Datseris G; Darivianaki K; Karidi E; Eliopoulos G; Delidis G; Rontogianni D; Kanavaros P
Anticancer Res; 1996; 16(2):827-31. PubMed ID: 8687136
[TBL] [Abstract][Full Text] [Related]
25. The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas.
Weinreb M; Day PJ; Niggli F; Powell JE; Raafat F; Hesseling PB; Schneider JW; Hartley PS; Tzortzatou-Stathopoulou F; Khalek ER; Mangoud A; El-Safy UR; Madanat F; Al Sheyyab M; Mpofu C; Revesz T; Rafii R; Tiedemann K; Waters KD; Barrantes JC; Nyongo A; Riyat MS; Mann JR
Arch Dis Child; 1996 Jan; 74(1):27-31. PubMed ID: 8660041
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
[TBL] [Abstract][Full Text] [Related]
27. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
[TBL] [Abstract][Full Text] [Related]
28. Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease.
Kordek R; Biernat W; Kupnicka D; Woźniak L
Pol J Pathol; 1994; 45(4):279-81. PubMed ID: 7697330
[TBL] [Abstract][Full Text] [Related]
29. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease.
Herbst H; Steinbrecher E; Niedobitek G; Young LS; Brooks L; Müller-Lantzsch N; Stein H
Blood; 1992 Jul; 80(2):484-91. PubMed ID: 1320954
[TBL] [Abstract][Full Text] [Related]
30. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: relation between latent membrane protein-1 positivity and clinical course.
De Bruin PC; Jiwa NM; Van der Valk P; Van Heerde P; Gordijn R; Ossenkoppele GJ; Walboomers JM; Meijer CJ
Histopathology; 1993 Dec; 23(6):509-18. PubMed ID: 8314234
[TBL] [Abstract][Full Text] [Related]
31. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.
Jiwa NM; Kanavaros P; van der Valk P; Walboomers JM; Horstman A; Vos W; Mullink H; Meijer CJ
J Clin Pathol; 1993 Mar; 46(3):211-7. PubMed ID: 8385158
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease?
Khan G; Gupta RK; Coates PJ; Slavin G
Am J Pathol; 1993 Nov; 143(5):1270-4. PubMed ID: 8238244
[TBL] [Abstract][Full Text] [Related]
33. Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease.
Enblad G; Sandvej K; Lennette E; Sundström C; Klein G; Glimelius B; Pallesen G
Int J Cancer; 1997 Jul; 72(3):394-7. PubMed ID: 9247279
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus genomes in Hodgkin's disease and non-Hodgkin's lymphomas.
Li D; Oda K; Mikata A; Yumoto N
Pathol Int; 1995 Oct; 45(10):735-41. PubMed ID: 8563934
[TBL] [Abstract][Full Text] [Related]
35. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico.
Quintanilla-Martínez L; Gamboa-Domńquez A; Gamez-Ledesma I; Angeles-Angeles A; Mohar A
Mod Pathol; 1995 Aug; 8(6):675-9. PubMed ID: 8532705
[TBL] [Abstract][Full Text] [Related]
36. Association of Hodgkin's lymphoma with Epstein Barr virus infection.
Cickusić E; Mustedanagić-Mujanović J; Iljazović E; Karasalihović Z; Skaljić I
Bosn J Basic Med Sci; 2007 Feb; 7(1):58-65. PubMed ID: 17489771
[TBL] [Abstract][Full Text] [Related]
37. [Epstein-Barr virus infection and the expression of bcl-2 proto-oncogene in Hodgkin's disease].
Liu C; Liao S; Gao Z
Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):155-7. PubMed ID: 10072857
[TBL] [Abstract][Full Text] [Related]
38. The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya.
Weinreb M; Day PJ; Niggli F; Green EK; Nyong'o AO; Othieno-Abinya NA; Riyat MS; Raafat F; Mann JR
Blood; 1996 May; 87(9):3828-36. PubMed ID: 8611709
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease.
Khan G; Naase MA
J Clin Pathol; 1995 Sep; 48(9):845-8. PubMed ID: 7490319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
